Skip to main content
Clinical Trials/NCT04243980
NCT04243980
Unknown
Not Applicable

Short Term Results of Short Anatomical Femoral Stem in Total Hip Arthroplasty - Prospective Study

HaEmek Medical Center, Israel0 sites50 target enrollmentFebruary 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Patient Compliance
Sponsor
HaEmek Medical Center, Israel
Enrollment
50
Primary Endpoint
Femoral anteversion
Last Updated
6 years ago

Overview

Brief Summary

A study that detect the femoral anteversion after total hip arthroplasty using short anatomical femoral stem compared to the contrast side

Registry
clinicaltrials.gov
Start Date
February 1, 2020
End Date
January 1, 2022
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Raja Hakim

Medical Doctor

HaEmek Medical Center, Israel

Eligibility Criteria

Inclusion Criteria

  • age 18-90
  • patients who had THR as an elective surgery
  • patients who had THR with short femoral anatomical stem

Exclusion Criteria

  • severe osteoporosis with Dorr C classification
  • s/p bilateral hip arthroplasty
  • non-complaint patients
  • revision surgery

Outcomes

Primary Outcomes

Femoral anteversion

Time Frame: Post-Operatively, through study completion, an average of 2 years

comparing femoral anteversion after THR using CT scan

Secondary Outcomes

  • Harris Hip Score(6 weeks, 3 month, 6 month post-operative)

Similar Trials